iRhythm Technologies Inc
$ 183.04
0.64%
03 Dec - close price
- Market Cap 5,897,392,000 USD
- Current Price $ 183.04
- High / Low $ 187.98 / 179.63
- Stock P/E N/A
- Book Value 3.79
- EPS -1.61
- Next Earning Report 2026-02-19
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.03 %
- ROE -0.53 %
- 52 Week High 212.00
- 52 Week Low 81.10
About
iRhythm Technologies, Inc. is a leading digital healthcare company based in San Francisco, California, specializing in advanced ambulatory electrocardiogram (ECG) monitoring solutions tailored for patients at risk of arrhythmias. Leveraging cutting-edge technology and proprietary algorithms, iRhythm delivers timely and accurate cardiac monitoring that enhances patient care and improves clinical outcomes. With a robust product portfolio and a steadfast commitment to innovation, the company is strategically positioned to transform cardiovascular diagnostics and streamline cardiac health management in the United States, solidifying its status as a vital contributor in the dynamic healthcare sector.
Analyst Target Price
$220.60
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-30 | 2025-07-30 | 2025-04-30 | 2025-02-20 | 2024-10-30 | 2024-08-01 | 2024-05-02 | 2024-02-22 | 2023-11-02 | 2023-08-03 | 2023-05-04 | 2023-02-23 |
| Reported EPS | 0.06 | -0.32 | -0.95 | 0.01 | -1.26 | -0.61 | -1.23 | -1.26 | -0.89 | -0.61 | -1.1 | -0.67 |
| Estimated EPS | -0.32 | -0.5278 | -0.6886 | -0.28 | -0.57 | -0.89 | -0.96 | -0.6 | -0.66 | -0.78 | -0.9 | -0.62 |
| Surprise | 0.38 | 0.2078 | -0.2614 | 0.29 | -0.69 | 0.28 | -0.27 | -0.66 | -0.23 | 0.17 | -0.2 | -0.05 |
| Surprise Percentage | 118.75% | 39.371% | -37.9611% | 103.5714% | -121.0526% | 31.4607% | -28.125% | -110% | -34.8485% | 21.7949% | -22.2222% | -8.0645% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-19 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.012 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: IRTC
2025-11-02 10:45:31
Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders. The firm encourages iRhythm shareholders who acquired shares on or before November 5, 2021, to contact them to discuss potential legal rights and options, including corporate governance reforms or financial incentives. Halper Sadeh LLC handles such actions on a contingent fee basis, emphasizing that shareholder participation can improve company policies and enhance shareholder value.
2025-10-16 20:43:00
iRhythm Technologies, Inc. announced it will release its Q3 2025 financial results on October 30, 2025, after market close, followed by a conference call. The article also provides details on insider trading activity (22 sales, 0 purchases in 6 months), hedge fund activity (167 add, 117 decrease positions in Q2 2025), and recent analyst ratings (8 buy, 0 sell ratings). Several analysts have issued price targets for IRTC, with a median target of $193.0.
2025-10-16 20:42:36
This article announces that iRhythm Technologies will report its third quarter 2025 financial results on October 30, 2025. The company will issue a press release after the market closes, followed by a conference call and webcast to discuss the results. The event will include a Q&A session with management.
2025-10-16 06:28:27
iRhythm Technologies (NASDAQ:IRTC) has received a consensus "Moderate Buy" rating from brokerages, based on recent analyst reports. Several firms have adjusted price targets and ratings, with analysts citing an "overweight" or "buy" rating. Insider activity and institutional investor movements show changes in holdings, while the company's stock has seen a 1.2% increase in its one-year low.
2025-10-15 16:04:57
Truist Securities raised its price target for iRhythm Technologies (IRTC) to $205.00 from $175.00, maintaining a 'Buy' rating. This update follows several other analysts who have recently adjusted their ratings and price targets for IRTC. iRhythm Technologies specializes in digital healthcare solutions for cardiac monitoring.
2025-10-14 23:48:37
This article from Investing.com reports that iRhythm's revenue surged by 26% in Q2 2025. The company also raised its full-year guidance based on this strong performance.
